Ariela Karmel

20 stories about Ariela Karmel
פארק עופר פארק ההייטק של יקנעם

"Growing high-tech is essential for the economy of the North"

25.07.24|Ariela Karmel
Israeli-High Tech Association CEO Maya Schwartz, who originally hails from the Golan Heights, spoke to CTech about the impact of the war on the tech industry in Israel’s north and the importance of supporting it amid Israel’s war with Hezbollah
Keren Halperin, Place-IL

Rebuilding tech in the Negev: “Working in tech offers the best chance at social mobility in Israel”

24.07.24|Ariela Karmel
Place-IL CEO Keren Halperin-Musseri spoke to CTech about their efforts to revive the tech industry in the Western Negev through matching employees with tech companies and also through the new co-working space that they have opened in Sderot to help keep tech workers in the region. 
Keren Leshem

OCON Therapeutics raises $10 million for innovative IUD and women’s health solutions

16.07.24|Ariela Karmel
The Israeli women’s health company has raised a total of $40 million to expand its health solutions including painless and effective IUDs and treatment for endometriosis and uterine fibroids
BioGenCell

BioGenCell pioneers revolutionary cell therapy for microvascular disease

11.07.24|Ariela Karmel
CEO Yael Porat spoke to CTech about the Israeli biotech company’s groundbreaking cell therapy technology for the common and debilitating disease whose primary treatment today is amputation 
New Phase

Groundbreaking Israeli cancer treatment gets FDA approval for clinical trials in U.S.

09.06.24|Ariela Karmel
New Phase CEO Ofer Shalev spoke to CTech about their technology which turns advanced cancer into a chronic ailment, extending the lifespans and treating symptoms without any of the side effects associated with other existing treatments 
CTech Paris Conference Samuel Attali

“France is the main gate to the European market”

30.05.24|Ariela Karmel
Samuel Attali, Co-Founder at Expand CPA, spoke to CTech about why Israeli entrepreneurs should expand their businesses in France during Israel’s Business Delegation to Paris led by Calcalist and Bank Hapoalim
CTech Paris Conference Michal Kissos Hertzog

“There are truly good reasons for us to be optimistic about the future of Israel”

29.05.24|Ariela Karmel
Michal Kissos Hertzog, CEO of Poalim Tech, spoke to CTech about AI, female representation in Israeli tech and Israel’s Business Delegation to Paris led by Calcalist and Bank Hapoalim
CTech Paris Conference Ariel Weil

Paris Centre Mayor: “We spend a lot of time discussing how to protect the Jewish community”

29.05.24|Ariela Karmel
Ariel Weil, Mayor of Paris Centre, spoke to CTech about his district, home to one of the largest Jewish communities in Paris, during Israel’s Business Delegation to Paris led by Calcalist and Bank Hapoalim.
CTech Paris Conference Julien Roitman

Israel France Chamber of Commerce Chairman: France is Israel’s gate to Europe

28.05.24|Ariela Karmel
Julien Roitman, Chairman of the Israel France Chamber of Commerce and Industry spoke to CTech about the advantages of the French market for Israeli tech during Israel’s Business Delegation to Paris led by Calcalist and Bank Hapoalim
CTech Paris Conference Isabelle Amiel-Azoulay

Sienna Venture Capital Partner: Now is the best time to invest in Israeli tech

28.05.24|Ariela Karmel
Isabelle Amiel, Founding Partner of Sienna Venture Capital spoke to CTech during Israel’s Business Delegation to Paris led by Calcalist and Bank Hapoalim about how less investor competition and resilient entrepreneurs makes this the best time to invest in Israeli tech 
CTech Paris Conference Jean-Emile Rosenblum

“Israelis need to understand that there is a good market in France”

28.05.24|Ariela Karmel
Jean-Emile Rosenblum, Founder and CEO of Pixmania and head of French Tech TLV spoke to CTech about French interest in Israeli tech during Israel’s Business Delegation to Paris led by Calcalist and Bank Hapoalim.
Rachel Teitelbaum

The Israeli startup developing the first new, non-hormonal contraceptive in 60 years

03.04.24|Ariela Karmel
Hervana Bio Founder and CEO Rachel Teitelbaum spoke to CTech about their innovative new non-hormonal contraceptive with no side effects and with added protection against STIs, and about why funding is needed to access the $25 billion contraceptive market